SAM #75N98026Q01067

Sole-source service contract for biospecimen and clinical data collection in pulmonary arterial hypertension research

This opportunity is a planned sole-source service contract by the NIH National Heart, Lung, and Blood Institute (NHLBI) for research support in pulmonary arterial hypertension (PAH. - Agency: National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) - Sole-source contract to The Johns Hopkins University - Service: Collection of biospecimens and clinical data from PAH patients - Includes 10 samples each from SSc-PAH, SSc without PAH, and IPAH patients - De-identified PBMC samples and associated clinical/demographic data - Blood sample collection, processing, cryopreservation, storage, and secure data sharing - Purpose: Support research on CAV1 deficiency in PAH - No specific products, part numbers, or equipment purchases - Period of performance: 12 months from award date - Commercial opportunity is limited due to sole-source nature, but similar research service providers may be interested in future requirements

Description

The Therapeutic Role of Soluble Adenylyl Cyclase Inhibition in Ameliorating Inflammatory Vascular Remodeling in Pulmonary Arterial Hypertension

View original listing